Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.
Baldini C, Younan N, Castanon Alvarez E, Ammari S, Alentorn A, Dumont S, Frenel JS, Di Stefano AL, Louvel G, Michot JM, Bahleda R, Postel-Vinay S, Varga A, Marabelle A, Hollebecque A, Bielle F, Hoang-Xuan K, Delattre JY, Dhermain F, Sanson M, Soria JC, Idbaih A, Massard C, Touat M.
Baldini C, et al. Among authors: dumont s.
Eur J Cancer. 2022 Mar;163:98-107. doi: 10.1016/j.ejca.2021.11.017. Epub 2022 Jan 18.
Eur J Cancer. 2022.
PMID: 35063776